Blocknomi
TLDR LLY stock drops 2.54% to $1,273.46 despite upbeat ovarian cancer trial data. Sofe-M combination delivers a 79.3% response rate in Phase 1 ovarian cancer study. All evaluable patients achieved…
Related articles
-
Strategy spends nearly 9 times as much on STRC as Bitcoin
Crypto.News Published 12.10.2026 12:43
-
Crypto Price Analysis, BTC, XRP, VVV, PUMP and AERO, October 9: Bitcoin and XRP Weakens, PUMP Test Support as Aerodrome Advances
The Crypto Basic Published 09.10.2026 06:11
-
Balaji’s Farcaster takeover sparks wave of account bans
Crypto.News Published 16.10.2026 06:00
-
Brevan Howard to use Ripple Prime for multi-asset brokerage, clearing and financing
The Block Published 06.10.2026 14:36
-
MARA Ships $83 Million in Bitcoin to Exchanges as Its Stock Sinks 45%
Bitcoin.com Published 19.10.2026 13:05
-
11 Days to Go: XRP Ledger Prepares Wide-Ranging Protocol Fixes
U.Today Published 11.10.2026 15:25
-
Pudgy Penguins gets support as billionaire buys 117 NFTs
Crypto.News Published 12.10.2026 04:53
-
Thailand SEC Approves Local Bitcoin and Ethereum ETFs, Effective October 16
BlockchainReporter Published 09.10.2026 18:36